• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    Overcoming barriers to cancer prevention and care

    Although scientists know more about cancer today than ever before, racial and ethnic minorities bear a disproportionate burden of cancer across the disease spectrum

    Specialized Histopathology Core: New Low Prices on Laser Capture Microdissection

    Following a recent market survey, we  have decided to substantially reduce the price of training and unassisted use  of the Laser Capture Microdissection System [PixCell II] available at the  Specialized Histopathology Services- Longwood Core

    Cancer pioneer Judah Folkman, MD, dies at 74

    DF/HCC member and cancer research pioneer Judah Folkman, MD, passed away on Jan

    Tissue Microarray Core has re-opened and added services

    As of December 3rd, all requests for Tissue Microarray and Nucleic Acid Isolation services should be submitted to the DF/HCC Tissue Microarray Core.  The core remains under the direction of Jon Aster, MD, PhD

    Nanoparticles on cell
    Brigham and Women's Hospital: Signature strengths advance cancer research

    Brigham and Women’s Hospital, renowned for excellence in patient care, research, and teaching, traces its roots in medicine back to 1832

    Q&A with Jeff Clark: Recent steps streamline clinical trials process

    The appointment of Jeffrey Clark, MD (MGH) as medical director of Clinical Trials Operations at DF/HCC became official about two months ago, but the helm is hardly new to him

    Wilms tumor with a WTX deletion
    “X” marks the spot for new Wilms’ tumor gene

    When investigators went hunting for a gene implicated in Wilms’ tumor – the most common pediatric kidney cancer – they found it in an unlikely spot

Displaying results 169 to 175 out of 223